3'OMe-m7GpppAmpG ammonium solution (100 mM)
Based on 1 Customer Validation
3’OMe-m7GpppAmpG (m7(3'OMeG)(5')ppp(5')(2'OMeA)pG) ammonium solution (100 mM) is a trinucleotide Cap1 analog with the structure m7 (3'OMeG)(5') ppp (5')(2'OMeA) pG, and also functions as a cis-acting ligase ribozyme inhibitor. 3’OMe-m7GpppAmpG ammonium solution (100 mM) effectively reduces free 5'-triphosphate groups on RNA transcripts, thereby enabling efficient co-transcriptional capping of in vitro transcribed mRNA. 3’OMe-m7GpppAmpG ammonium solution (100 mM) is not only widely used in the preparation of modified mRNA including trivalent influenza vaccine candidates, but also applicable to studies related to SARS-CoV-2 infection and other relevant research.
For research use only. We do not sell to patients.
- Purity: 98.24%
- Formula: C33H45N15O24P4.xNH3
-
Storage:
Solution, -20°C, 2 years
Biological Activity
Chemical Information
-
Appearance Liquid
-
Formula C33H45N15O24P4.xNH3
-
Color Colorless to light yellow
-
SMILES
O[C@@H]1[C@H](OC)[C@@H](COP(OP(OP(OC[C@@H]2[C@@H](OP([O-])(OC[C@@H]3[C@@H](O)[C@@H](O)[C@H](N4C(N=C(N)NC5=O)=C5N=C4)O3)=O)[C@@H](OC)[C@H](N6C(N=CN=C7N)=C7N=C6)O2)(O)=O)(O)=O)(O)=O)O[C@H]1N8C(N=C(N)NC9=O)=C9[N+](C)=C8.[x].N
-
Synonyms
m7(3'OMeG)(5')ppp(5')(2'OMeA)pG ammonium solution (100 mM)
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Solution, -20°C, 2 years
Purity & Documentation
-
Data Sheet (271 KB)
-
SDS (252 KB)
- English - EN (252 KB)
- Français - FR (252 KB)
- Deutsch - DE (252 KB)
- Norwegian - NO (252 KB)
- Español - ES (252 KB)
- Swedish - SV (252 KB)
- Italian - IT (252 KB)
- Korean - KR (252 KB)
- Portuguese - PT (252 KB)
-
Handling Instructions (2659 KB)
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
- 3'OMe-m7GpppAmpG ammonium solution (100 mM)
- m7(3'OMeG)(5')ppp(5')(2'OMeA)pG ammonium solution (100 mM)
- Nucleoside Antimetabolite/Analog
- SARS-CoV
- SARS-CoV-2 infection
- HA protein
- cis-acting ligase ribozyme
- RNA transcripts
- SARS-CoV-2 spike mRNA
- mRNA
- trivalent influenza vaccine
- HEK293 cells
- LNP formulation
- Inhibitor
- inhibitor
- inhibit